OGIVRI vs TOLAK

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 13, 2026·How we rate

Possible drug interaction. OGIVRI and TOLAK are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	OGIVRI	TOLAK
Rating	66/100	72/100
Pharmacy pays	—	$0.61 /mL
Type	RX	RX
Active ingredient	TRASTUZUMAB-DKST	FLUOROURACIL
Manufacturer	Mylan Gmbh	Hill Dermaceuticals
Dosage forms	Injectable, Kit	Topical
Drug class	—	Nucleoside Metabolic Inhibitor
Boxed warning	Boxed warning	None
Treats	Breast Neoplasms, Gastrointestinal Neoplasms	Breast Neoplasms, Basal Cell Carcinoma, Colonic Neoplasms

ogivri tolak

Rating

66/100

72/100

Pharmacy pays

—

$0.61 /mL

Type

Active ingredient

TRASTUZUMAB-DKST

FLUOROURACIL

Manufacturer

Mylan Gmbh

Hill Dermaceuticals

Dosage forms

Injectable, Kit

Topical

Drug class

—

Nucleoside Metabolic Inhibitor

Boxed warning

None

Treats

Breast Neoplasms, Gastrointestinal Neoplasms

Breast Neoplasms, Basal Cell Carcinoma, Colonic Neoplasms

Frequently asked questions

Which is better-rated, Ogivri or Tolak?

By our independent rating, Tolak scores higher — 3.6 vs 3.3 out of 5 for Ogivri. Ratings are based on FDA regulatory (recall-safety) data.

What is the difference between Ogivri and Tolak?

Ogivri contains Trastuzumab-Dkst, while Tolak contains Fluorouracil — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.